Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hella L Aberson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biomedicines|February 25, 2022
Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent MannerC Arnold Spek, Hella L Aberson, JanWillem Duitman
BMC Cancer|December 3, 2020
Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretionCansu Tekin, Hella L Aberson, Maarten F Bijlsma, et al.
Journal of Cellular and Molecular Medicine|January 31, 2025
Identification of C/EBPδ-Modifying Compounds as Potential Anticancer Agents Using a High-Throughput Drug ScreenLeonie Hartl, JanWillem Duitman, Hella L Aberson, et al.
Cells|September 28, 2021
CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional ProgramsC Arnold Spek, Hella L Aberson, Joe M Butler, et al.
International Journal of Molecular Sciences|September 14, 2024
Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic CancerLeonie Hartl, Marieke S Ten Brink, Hella L Aberson, et al.
Nucleic Acids Research|November 25, 2003
Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathwaysEric Eldering, C Arnold Spek, Hella L Aberson, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 19, 2020
Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activationCansu Tekin, Hella L Aberson, Cynthia Waasdorp, et al.
International Journal of Cancer|January 18, 2014
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistanceKarla C S Queiroz, Kun Shi, JanWillem Duitman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 18, 2009
Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammationSarah T B G Loubele, C Arnold Spek, Peter Leenders, et al.
Molecular Medicine (Cambridge, Mass.)|July 1, 2011
Tissue factor-dependent chemokine production aggravates experimental colitisKarla C S Queiroz, Cornelis Van 't Veer, Yascha Van Den Berg, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomedicines|February 25, 2022
Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent MannerC Arnold Spek, Hella L Aberson, JanWillem Duitman
BMC Cancer|December 3, 2020
Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretionCansu Tekin, Hella L Aberson, Maarten F Bijlsma, et al.
Journal of Cellular and Molecular Medicine|January 31, 2025
Identification of C/EBPδ-Modifying Compounds as Potential Anticancer Agents Using a High-Throughput Drug ScreenLeonie Hartl, JanWillem Duitman, Hella L Aberson, et al.
Cells|September 28, 2021
CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional ProgramsC Arnold Spek, Hella L Aberson, Joe M Butler, et al.
International Journal of Molecular Sciences|September 14, 2024
Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic CancerLeonie Hartl, Marieke S Ten Brink, Hella L Aberson, et al.
Nucleic Acids Research|November 25, 2003
Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathwaysEric Eldering, C Arnold Spek, Hella L Aberson, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 19, 2020
Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activationCansu Tekin, Hella L Aberson, Cynthia Waasdorp, et al.
International Journal of Cancer|January 18, 2014
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistanceKarla C S Queiroz, Kun Shi, JanWillem Duitman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 18, 2009
Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammationSarah T B G Loubele, C Arnold Spek, Peter Leenders, et al.
Molecular Medicine (Cambridge, Mass.)|July 1, 2011
Tissue factor-dependent chemokine production aggravates experimental colitisKarla C S Queiroz, Cornelis Van 't Veer, Yascha Van Den Berg, et al.
Pageof 2